Table 2.
Conditional 5-year relative survival estimates, by type of cancer, disease stage and number of years since diagnosis, for patients aged 15–89 years at diagnosis, NSW Australia 1998-2006
| Type of cancer | Number of patients |
Estimated conditional 5-year relativesurvival |
||||
|---|---|---|---|---|---|---|
| At diagnosis | 1 year after diagnosis | 3 years after diagnosis | 5 years after diagnosis | 10 years after diagnosis | ||
|
Localised | ||||||
| Stomach |
1247 |
54.4 |
75.0 |
90.3 |
94.7 |
93.8 |
| Colorectum |
11450 |
89.6 |
93.3 |
95.1 |
97.4 |
99.0 |
| Pancreas |
849 |
9.9 |
24.7 |
65.1 |
76.5 |
98.5 |
| Lung |
5202 |
32.9 |
51.2 |
73.2 |
80.0 |
82.4 |
| Melanoma† |
20077 |
99.2 |
98.9 |
98.7 |
99.1 |
99.3 |
| Breast (females) |
19468 |
97.2 |
96.6 |
95.8 |
95.8 |
95.4 |
| Cervix |
1157 |
86.3 |
88.9 |
94.5 |
96.9 |
96.2 |
| Prostate |
18308 |
97.9 |
97.1 |
96.0 |
94.2 |
90.6 |
| Kidney |
3734 |
87.8 |
89.8 |
91.3 |
90.9 |
90.1 |
| Bladder |
3111 |
72.7 |
79.1 |
85.5 |
88.6 |
92.0 |
| Thyroid |
2920 |
99.7 |
100.0 |
99.5 |
99.4 |
99.2 |
|
Regional | ||||||
| Stomach |
1881 |
28.7 |
41.9 |
68.2 |
85.9 |
97.7 |
| Colorectum |
14965 |
67.2 |
71.5 |
82.0 |
90.1 |
98.5 |
| Pancreas |
965 |
8.2 |
19.3 |
61.3 |
84.2 |
95.9 |
| Lung |
4270 |
18.7 |
32.3 |
58.3 |
68.6 |
81.7 |
| Melanoma† |
4563 |
73.8 |
73.4 |
81.2 |
86.9 |
99.3 |
| Breast (females) |
12552 |
83.7 |
81.5 |
83.3 |
84.8 |
89.2 |
| Cervix |
616 |
59.7 |
67.5 |
80.8 |
89.0 |
92.4 |
| Prostate |
2237 |
87.8 |
88.3 |
89.0 |
88.3 |
81.7 |
| Kidney |
1202 |
54.7 |
65.3 |
81.3 |
89.4 |
82.8 |
| Bladder |
965 |
36.4 |
51.0 |
75.2 |
86.0 |
95.1 |
| Thyroid |
863 |
92.6 |
96.2 |
96.1 |
94.7 |
96.1 |
|
Distant | ||||||
| Stomach |
1289 |
5.2 |
20.6 |
81.2 |
93.4 |
95.5 |
| Colorectum |
5576 |
11.9 |
23.9 |
56.4 |
83.4 |
93.9 |
| Pancreas |
2059 |
2.3 |
20.4 |
62.4 |
83.2 |
98.7 |
| Lung |
8000 |
2.8 |
14.4 |
59.2 |
83.5 |
98.7 |
| Melanoma† |
1222 |
32.3 |
54.6 |
79.3 |
84.1 |
91.2 |
| Breast (females) |
1769 |
39.4 |
48.6 |
59.8 |
67.6 |
82.5 |
| Cervix |
149 |
18.4 |
40.0 |
71.2 |
76.3 |
93.6 |
| Prostate |
1577 |
16.8 |
25.9 |
43.4 |
53.6 |
80.7 |
| Kidney |
1031 |
6.4 |
20.3 |
59.1 |
65.9 |
76.7 |
| Bladder |
376 |
4.6 |
17.3 |
52.5 |
92.6 |
73.6 |
| Thyroid |
161 |
50.0 |
70.9 |
79.7 |
85.9 |
91.1 |
|
Unknown | ||||||
| Stomach |
776 |
27.7 |
53.9 |
81.7 |
88.8 |
85.3 |
| Colorectum |
3464 |
64.5 |
77.8 |
87.9 |
92.1 |
96.8 |
| Pancreas |
1340 |
6.9 |
23.3 |
67.7 |
81.3 |
77.5 |
| Lung |
5555 |
10.9 |
21.9 |
54.8 |
71.2 |
84.9 |
| Melanoma† |
2026 |
94.4 |
93.6 |
94.2 |
95.1 |
99.0 |
| Breast (females) |
2796 |
78.5 |
81.0 |
86.6 |
90.4 |
93.9 |
| Cervix |
446 |
74.9 |
83.4 |
90.6 |
95.7 |
92.2 |
| Prostate |
17729 |
90.0 |
88.7 |
88.6 |
86.9 |
89.4 |
| Kidney |
973 |
51.5 |
66.8 |
79.6 |
85.7 |
88.7 |
| Bladder |
1702 |
69.8 |
79.7 |
89.5 |
92.5 |
88.2 |
| Thyroid | 564 | 94.2 | 98.6 | 99.4 | 99.9 | 96.5 |
† Thickness of the lesion was also used to categorise disease stage at diagnosis for melanoma [T3 (thickness = 2.01-4.0 mm) and T4 (thickness > 4.0 mm) stages were grouped with ‘spread to regional lymph nodes’ as ”regional”]. Since thickness data prior to 1983 were considered unreliable, we used melanoma data from 1983 onward for the stage-specific survival estimates.